On the basis of that the fluorescence wavelength of copper nanoclusters(CuNCs)could cover the entire visible region,multicolor fluorescent CuNCs/starch composites were prepared and applied in fingermark development.With L-glutathione as the reducing agent and protective ligand,blue emissive and orange emissive CuNCs solutions were obtained in alkaline solutions at 90℃and 25℃,respectively.With the aggregation-induced emission effect induced by ethanol as a poor solvent,the fluorescence of orange emissive CuNCs with a higher intensity was achieved in an ethanol-water solution.With ascorbic acid as the reducing agent and 3-mercaptopropionic acid as the protective agent,green emissive CuNCs solution was prepared in an acid solution.Particle morphologies,chemical compositions and optical properties of these three CuNCs above were investigated using physical characterization and spectroscopic analysis,indicating that well-dispersed CuNCs had excellent photoluminescent properties.These CuNCs solutions were combined with starch to form composite powders by simply drying.The influences of the type of CuNCs and the ratio of CuNCs to starch on the emission wavelength and fluorescence intensity of the products were studied.The obtained CuNCs/starch composites could emit blue,green and orange fluorescence under 365 nm ultraviolet light,respectively,which were suitable for fingermark development.Minutiae and partial level-3 features of latent fingermarks could be effectively developed.High-quality fluorescence fingermark images would be captured using appropriate optical filters to eliminate background interference of various substrates.

Molecular biology experimental skills have become essential for medical and pharmaceutical undergraduates engaged in scientific research practice.To meet the training needs of molecular biology skills in different disciplines and majors,this study establishes a cross-major,cross-disciplinary,and cross-nationality scientific research mutual assistance group.The training of molecular biology experimen-tal skills was combined with a large-scale senior thesis design,where students collectively practiced and mastered a variety of molecular biology skills such as polymerase chain reaction,protein immunoblotting,and enzyme-linked immunosorbent assay in a comprehensive experiment.The implementation of this sci-entific research mutual assistance group model received positive feedbacks from students,who found that their molecular biology skills had significantly improved.The scores of the 'Molecular Biology' exam for the pharmaceutical and biological science major members of the research group were 80.7 and 72.5,re-spectively,which were significantly higher than the average scores of 74.77 and 67.26 for the same ma-jors.The comprehensive ability of students in molecular biology was enhanced.Multiple members of the research group participated in provincial biopharmaceutical skill competitions and won several second and third prizes.They were successfully funded for six undergraduate innovation and entrepreneurship pro-jects,including one provincial-level and five university-level projects,thus effectively improving students' scientific research and innovation capabilities.The thesis defense score of the research group members was 86.12,significantly higher than the average score of 83.43 for all members of the same de-fense group,indicating a significant improvement in students' senior thesis design level and comprehen-sive quality.The rate of the research group members to continue their graduate school study was 90％,significantly higher than the average enrollment rate of 38.61％for the same defense group.Taken to-gether,the establishment of a multidisciplinary cross-research mutual assistance group based on senior thesis optimized teaching resources,integrated teaching advantages,and effectively improved undergradu-ates' molecular biology experimental skills and scientific research skills.

Acquired resistance to the proteasome inhibitor bortezomib(BTZ)poses a significant chal-lenge in the treatment of multiple myeloma(MM).During the acquisition of BTZ resistance,metabolic reprogramming is actively engaged in MM cells.However,the key regulatory genes and molecular mecha-nisms mediating bortezomib resistance through this metabolic rewiring have not been fully elucidated.This study aims to investigate the regulatory role of pyrimidine metabolites in drug resistance of MM and their underlying molecular mechanisms.Screening via CCK-8 assays demonstrated that the pyrimidine metabolite uridine is associated with BTZ resistance in MM(P＜0.05).In vitro experiments,including CCK-8 assays,Western blotting,and flow cytometry,demonstrated that uridine partially suppresses bort-ezomib-induced apoptosis in MM cells(P＜0.05).In vivo,experiments utilizing Vk*MYC mouse mod-els,subcutaneous tumor models,and intramedullary bone marrow transplantation models showed that the combination of BTZ and uridine significantly accelerated tumor growth,exacerbated bone destruction,and increased tumor cell infiltration in tumor-bearing mice(P＜0.05).RNA sequencing analysis re-vealed that uridine primarily affects mitochondrial translation in MM at the transcriptional level.Seahorse energy metabolism assays demonstrated that uridine enhances mitochondrial oxidative phosphorylation without significantly altering glycolysis.Transcriptomic analysis further identified a significant upregula-tion of cytochrome c oxidase subunit 5B(COX5B)transcription in uridine-treated groups(P＜0.05).Functional studies confirmed that COX5B is a key molecule mediating uridine's effects on mitochondrial function in MM cells.In conclusion,uridine promotes BTZ resistance in MM by upregulating COX5B transcription and protein expression,thereby enhancing cytochrome c oxidase activity and regulating mito-chondrial oxidative phosphorylation.This study delineates the role of uridine in the development of borte-zomib resistance in MM and elucidates its COX5B-mediated metabolic reprogramming mechanism,provi-ding a theoretical foundation for developing targeted therapies against relapsed/refractory MM.

Multiple myeloma(MM)is the second most common hematological malignancy,predominant-ly affecting the elderly.With the development of an aging society in China,the incidence of MM has been steadily increasing,becoming a significant concern for public health and a considerable socioeco-nomic burden.Over the past two decades,breakthroughs have been achieved in both clinical manage-ment and basic research on MM.However,the field now stands at a crossroads for the next phase,facing numerous developmental directions and challenges.

Mesenchymal stem cells(MSCs)induces fusion of multiple monocyte macrophages by secre-ting key cytokines such as receptor activator for nuclear factor-κB ligand(RANKL)and macrophage CSF(M-CSF)to form multinucleated macrophages thereby SUMO-specific protease 3(SENP3)modifies pro-teins by de-SUMOylation,which in turn affects the stability,localization and activity of substrate pro-teins.Based on the previous work in our laboratory,we found that the number of osteoclasts increased in mice with SENP3 knockdown in MSC(***P＜0.001).To further explore the mechanism,using immuno-fluorescence as well as Western blotting assay,we found that knockdown of the Hedgehog(Hh)signaling pathway by SENP3 increased the transcription factor glioma-associated oncogene homolog 2(Gli2),which is the most important transcription factor for the production of osteoclasts.CHIP-qPCR results showed that Gli2 promoted COX2 transcription by binding to cyclooxygenase-2(COX2)promoter regions-1 235～-1 249 and-1 158～-1 172(*P＜0.05);meanwhile,the main secretion product of COX2,pep-tide,was detected by ELISA(*P＜0.05).The level of prostaglandin E2(PGE2),the main secretory product of COX2,was increased in the supernatant of the culture medium of MSC with knockdown of SENP3 by ELISA(***P＜0.001).PGE2 is known to mediate cell migration and osteoclastogenesis through E-type prostanoid receptor 2(EP2)and E-type prostanoid receptor 4(EP4).In the study,the expression of EP4 receptor was found to be elevated in differentiated osteoclasts(**P＜0.01).The inhib-itors of the EP4 receptor significantly reduced the expression of nuclear factor-activated T cell 1(NFATc1),Cathepsin K(Ctsk),and tartrate resistant acid phosphatase(TRAP)genes(*P＜0.05)and decreased osteoclastogenesis(***P＜0.001),suggesting that EP4 receptors play a critical role in PGE2-mediated osteoclast differentiation.In conclusion,SENP3 deletion in mouse MSCs promotes COX2 transcription and PGE2 secretion through activation of the Hh signaling pathway thereby promoting osteo-clast formation.

With the rapid development of generative artificial intelligence(GAI)technologies,their widespread application in academic research and writing is continuously expanding the boundaries of sci-entific inquiry.However,this trend has also raised a series of ethical and regulatory challenges,inclu-ding issues related to authorship,content authenticity,citation accuracy,and accountability.In light of the growing involvement of AI in generating academic content,establishing an open,controllable,and trustworthy ethical governance framework has become a key task for safeguarding research integrity and maintaining trust within the academic community.This expert consensus outlines ethical requirements across key stages of AI-assisted academic writing-including topic selection,data management,citation practices,and authorship attribution.It aims to clarify the boundaries and ethical obligations surrounding AI use in academic writing,ensuring that technological tools enhance efficiency without compromising in-tegrity.The goal is to provide guidance and institutional support for building a responsible and sustainable research ecosystem.

Multiple myeloma(MM)is a hematologic malignancy characterized by clonal proliferation of plasma cells within the bone marrow,with pathological features including abnormal secretion of mono-clonal immunoglobulins,osteolytic bone disease,and multi-organ dysfunction.Despite significant ad-vancements in therapeutic approaches that have markedly extended patient survival,primary drug resist-ance and relapse remain major obstacles to clinical cure.The pathogenesis and progression of MM are in-tricately regulated by the bone marrow microenvironment(BMME),a dynamic network composed of di-verse cellular and non-cellular components.The BMME not only supports the survival and proliferation of MM cells but also plays a pivotal role in disease progression by modulating bone metabolic homeostasis,mediating immune escape,and promoting drug resistance.In recent years,groundbreaking therapeutic strategies targeting the BMME have emerged,including immunomodulatory drugs,bispecific antibodies,CAR T-cell therapies,and microenvironment-modulating agents.These approaches have significantly im-proved objective response rates and survival outcomes in relapsed/refractory MM by disrupting cytokine signaling,reprogramming the immunosuppressive microenvironment,or inhibiting tumor-stromal interac-tions.However,challenges such as drug resistance,treatment-related toxicity,and tumor heterogeneity persist in clinical practice.This review systematically delineates the roles of BMME components in MM pathogenesis,analyzes the molecular mechanisms underlying MM cell-BMME interactions,and explores innovative strategies to enhance therapeutic efficacy and prognosis through targeted modulation of the BMME.These insights provide a foundation for developing novel therapeutic paradigms aimed at overco-ming current limitations in MM treatment.

CRY1/2,as important transcriptional regulators of the circadian clock system,play a crucial role in maintaining metabolic homeostasis in body.This article analyzes existing re-search and focuses on the regulatory mechanisms of CRY1/2 in glucose and lipid metabolism.CRY1 plays an important regula-tory role in gluconeogenesis,glycolysis and insulin secretion,maintaining blood glucose homeostasis by regulating the expres-sion of key enzymes.Additionally,CRY1/2 regulate lipid me-tabolism by modulating fat synthesis and absorption,thereby af-fecting energy balance in the body.This article also discuss the potential applications of CRY1/2 in obesity and xenobiotic de-toxification,highlighting their potential value as therapeutic tar-gets.As core factors in metabolic regulation,CRY1/2 have sig-nificant clinical application prospects,and a deeper understand-ing of their molecular mechanisms in glucose and lipid metabo-lism will provide new ideas and strategies for the treatment of chronic metabolic diseases.

This study was aimed at exploring novel auxiliary diagnostic biomarkers for brucellosis and their potential miR-NA-mRNA regulatory networks.High-throughput sequencing was used to compare miRNA expression differences in serum ex-osomes between patients with brucellosis and healthy controls.Subsequently,RT-qPCR was used to validate the expression of significantly upregulated exosomal miRNAs.The diagnostic value of these miRNAs was assessed with ROC curves,and bioin-formatics analyses were performed to investigate the potential roles of the miRNAs in brucellosis infection.The ROC curve a-nalysis indicated that the area under the curve for exosomal hsa-miR-11400(P＜0.05),hsa-miR-199a-5p(P＜0.05),and hsa-miR-148a-5p(P＜0.05)was 0.79,0.81,and 0.74,respectively.A total of 465 differentially expressed miRNAs and their tar-get genes were predicted,including 25 immune-related target genes,most of which were closely associated with cancer-related proteoglycans,NF-kappa B signaling pathways,and IL-17 signaling pathways.The constructed differentially expressed gene network indicated that the immune genes PLXNA2,IL17RA,PRKCA,CD22,ACVR1B,and CBL might be regulated by hsa-miR-199a-5p and hsa-miR-148a-5p.These findings suggest that exosomal miRNAs might serve as auxiliary diagnostic indicators for brucellosis.Our exosomal miRNA-mRNA regulatory network provides new insights into the pathogenesis and treatment of brucellosis.

In view of the characteristics of H5N6 subtype avian influenza virus(AIV)that it has both high pathogenicity and the risk of cross-species transmission,posing a serious threat to the poultry farming industry and public health security,in order to effectively prevent and control the spread of H5N6 avian influenza,a rapid,sensitive and specific detection technolo-gy was established in this study.The specific monoclonal antibodies against the neuraminidase N6 protein of avian influenza A virus subtype H5N6 were obtained through hybridoma and monoclonal antibody technology.These antibodies were coupled and labeled with carboxyl-functionalized fluorescent quantum dots,along with previously prepared specific antibodies against the hemagglutinin H5 protein.A rapid fluorescence immunochromatographic detection method for the H5N6 subtype of avian influ-enza virus was established according to the principle of double-antibody sandwich immunochromatography.This method a-chieved a detection sensitivity of 1 ng/mL for recombinant hemagglutinin H5 subtype protein and 0.1 ng/mL for recombinant neuraminidase N6 subtype protein.Moreover,the method exhibited no cross-reactivity with other influenza subtypes or patho-gens,such as Newcastle disease(ND),infectious bronchitis(IB),and infectious laryngotracheitis(ILT),thus demonstrating good specificity.The method effectively identified the highly pathogenic avian influenza virus H5 subtype and directly distin-guished the H5N6 subtype with good accuracy.The fluorescent quantum dot immunochromatographic typing detection method established herein met the sensitivity,specificity,and accuracy requirements for H5N6 subtype detection,and can be further used for rapid detection of the H5 and H5N6 subtypes of avian influenza virus.